Abstract
Asymptomatic T1 (invaded submucosa) esophageal carcinoma rarely metastasizes to the brain. A 53-year-old Japanese man complaining of right hemiparesis and convulsion was admitted to our hospital. Brain imaging demonstrated a ring-like, enhanced brain tumor in the left parietal lobe. The pathological findings of the resected tumor were consistent with a metastatic adenocarcinoma from the gastrointestinal tract. Additional examinations revealed an elevated-type tumor in the lower third of the thoracic esophagus. The patient underwent thoracoscopic esophagectomy with lymph node dissection followed by reconstruction with gastric tube substitution. The immunohistochemical findings of the resected specimen were similar to those of the metastatic brain tumor. Although the patient received adjuvant chemotherapy (5-fluorouracil, docetaxel plus cisplatin), a solitary small brain metastasis was detected 4 months after esophagectomy. Excision of the sequential metastases with whole-brain radiation therapy and gamma-knife therapy were performed. The patient survived for 50 months after beginning the initial treatment. This report describes a rare case of brain metastases from T1 esophageal adenocarcinoma in a patient without gastrointestinal symptoms.
Similar content being viewed by others
References
Hori M, Matsuda T, Shibata A, et al. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2015;45:884–91.
Rubenstein JH, Shaheen NJ. Epidemiology, diagnosis, and management of esophageal adenocarcinoma. Gastroenterology. 2015;149:302–17.
Yoshida S. Brain metastasis in patients with esophageal carcinoma. Surg Neurol. 2007;67:288–90.
Gabrielsen TO, Eldevik OP, Orringer MB, et al. Esophageal carcinoma metastatic to the brain: clinical value and cost-effectiveness of routine enhanced head CT before esophagectomy. AJNR Am J Neuroradiol. 1995;16:1915–21.
Ogawa K, Toita T, Sueyama H, et al. Brain metastases from esophageal carcinoma: natural history, prognostic factors, and outcome. Cancer. 2002;94:759–64.
Quint LE, Hepburn LM, Francis IR, et al. Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma. Cancer. 1995;76:1120–5.
Burkitt P, Carter LM, Smith AB, et al. Outcomes of percutaneous endoscopic gastrostomy and radiologically inserted gastrostomy in patients with head and neck cancer: a systematic review. Br J Oral Maxillofac Surg. 2011;49:516–20.
Song Z, Lin B, Shao L, Zhang Y. Brain metastases from esophageal cancer: clinical review of 26 cases. World Neurosurg. 2014;81:131–5.
Weinberg JS, Suki D, Hanbali F, et al. Metastasis of esophageal carcinoma to the brain. Cancer. 2003;98:1925–33.
Chaichana KL, Gadkaree S, Rao K, et al. Patients undergoing surgery of intracranial metastases have different outcomes based on their primary pathology. Neurol Res. 2013;35:1059–69.
Batson OV. The function of the vertebral veins and their role in the spread of metastases. Ann Surg. 1940;112:138–49.
Bekki Y, Kimura Y, Morita M, et al. Esophageal cancer associated with bilateral hilar lymphadenopathy caused by sarcoid-like reactions: a report of two cases. Esophagus. 2015;12:322–6.
Feng W, Zhang P, Zheng X, et al. Incidence and treatment of brain metastasis in patients with esophageal carcinoma. World J Gastroenterol. 2015;21:5805–12.
Abu Hejleh T, Deyoung BR, Engelman E, et al. Relationship between HER-2 overexpression and brain metastasis in esophageal cancer patients. World J Gastrointest Oncol. 2012;4:103–8.
Preusser M, Berghoff AS, Ilhan-Mutlu A, et al. Brain metastases of gastro-oesophageal cancer: evaluation of molecules with relevance for targeted therapies. Anticancer Res. 2013;33:1065–71.
Safran H, Dipetrillo T, Akerman P, et al. Phase I/II study of trastuzumab, paclitaxel, cisplatin and radiation for locally advanced, HER2 overexpressing, esophageal adenocarcinoma. Int J Radiat Oncol Biol Phys. 2007;67:405–9.
Kim JC, Lee JL, Yoon YS, et al. Utility of indocyanine-green fluorescent imaging during robot-assisted sphincter-saving surgery on rectal cancer patients. Int J Med Robot. 2016;12:710–7.
Cinar P, Calkins SM, Venook AP, et al. A case series of patients with HER2-overexpressed primary metastatic gastroesophageal adenocarcinoma. Anticancer Res. 2014;34:7357–60.
Joo HY, Chae MH, Lim JH, et al. A case of gastric cancer manifesting as a solitary brain metastasis in the cerebellopontine angle that mimicked acoustic neuroma. Chonnam Med J. 2013;49:133–5.
Kothari N, Mellon E, Hoffe SE, et al. Outcomes in patients with brain metastasis from esophageal carcinoma. J Gastrointest Oncol. 2016;7:562–9.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Human rights
All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Informed consent
Informed consent was obtained from the patient and patient’s family to be included in the study.
Rights and permissions
About this article
Cite this article
Matsutani, T., Hagiwara, N., Nomura, T. et al. Long-term survival after multidisciplinary therapy for brain metastases from asymptomatic esophageal adenocarcinoma. Clin J Gastroenterol 11, 113–117 (2018). https://doi.org/10.1007/s12328-017-0803-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12328-017-0803-7